$117.88+24.07% · 3M
Moving avg
1W+2.49%
1M+6.09%
3M+24.07%
6M+16.60%
YTD+20.10%
1Y+33.95%
3Y+0.07%
5Y-35.33%
52-week range
$81.2299% of range$118.30
Company health
Value2/6
Growth2/6
Profitability4/6
Health5/6
Dividend4/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (328%)
Risks
- Richly valued at 53.9x earnings
Key statistics
Valuation
Market cap
$13.15B
Enterprise value
$15.11B
P/E ratio (TTM)
53.85x
P/S ratio (TTM)
4.35x
EV/EBITDA
19.55x
Per share & returns
EPS (TTM)
$2.15
Dividend yield
0.25%
Beta (1Y)
1.09
30-day change
+6.09%
Trading
Volume (24h)
963.34K
Previous close
$115.73
Shares outstanding
111.56M
About Revvity, Inc.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NYSE
Symbol
RVTY
Revvity, Inc. is a large-cap healthcare company in the Medical - Diagnostics & Research industry. Its shares are listed on NYSE (United States) and trade under the ticker RVTY.
Frequently asked questions
What is Revvity, Inc.'s market cap?
Revvity, Inc. (RVTY) has a market capitalization of $13.15B.
What is Revvity, Inc.'s P/E ratio?
Revvity, Inc. trades at a price-to-earnings (P/E) ratio of 53.85.
What exchange does RVTY trade on?
RVTY trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 364.10-0.38%
$356.08B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 123.56-0.52%
$288.54B cap
AstraZeneca PLCLON: AZN
£116.36-0.56%
$243.25B cap